Apotex Inc.
USPTO Trademark & Patent Filings
Trademark applications and grants for Apotex Inc.. Apotex Inc. has 73 trademark applications. The latest application filed is for "IPHARMACIST"
- Company Aliases
- APOTEX INC.
- APOTEX, INC.
- Apotex Inc. - Toronto CA
| State Incorporated | CANADA |
| Entity Type | CORPORATION |
| Address | 150 Signet Drive Toronto, Ontario CANADA M9L1T9 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| Crystalline Forms of Tenofovir Alafenamide 20220235079 - 17/159238 Souza; Fabio E. S. ; et al. | 2022-07-28 |
| Crystalline Form of Remdesivir 20220144866 - 17/601493 Souza; Fabio E. S. ; et al. | 2022-05-12 |
| Processes for the Preparation of Zuclomiphene Intermediates 20220119331 - 17/503727 Patel; Dineshkumar ; et al. | 2022-04-21 |
| Salts of Zuclomiphene 20210292272 - 17/206362 Souza; Fabio E. S. ; et al. | 2021-09-23 |
| Crystalline Forms of Zuclomiphene Citrate 20210221767 - 17/154261 Souza; Fabio E. S. ; et al. | 2021-07-22 |
| NCAGE Code | 38789 | APOTEX INC |
| CAGE Code | 38789 | APOTEX INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 